LICENSE AGREEMENT between AstraZeneca AB and Sierra Oncology, Inc., Dated as of August 03, 2021License Agreement • November 5th, 2021 • Sierra Oncology, Inc. • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”) is made and entered into as of the date last signed (the “Effective Date”) by and between AstraZeneca AB, a company incorporated in Sweden, with its principal place of business at SE-151 85, Södertälje, Sweden (“AstraZeneca”) and Sierra Oncology, Inc., a Delaware corporation with offices at 1820 Gateway Drive, Suite 110 San Mateo, CA 94404 USA (“Licensee”). AstraZeneca and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
